Based on a recent article by Gao et al., MALAT1 upregulation in AML influences apoptosis, proliferation, and drug sensitivity and is associated with poor prognosis, higher WBC and platelet counts, and shorter OS [20]. Here, MALAT1 is linked to acute myeloid leukemia.